ADILW
Adial Pharmaceuticals, Inc. WT EXP 073123
NASDAQHealthcareBiotechnologyUS
Company Profile
IPO Date
2018-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Adial Pharmaceuticals, Inc. WT EXP 073123
IPO Date
2018-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 40,000 |
| $0.30 |
| 25 May 2023 | Claiborne Cary J | director, officer: Chief Executive Officer | A-Award | Acquired | 420,000 | $0.00 |
| 25 May 2023 | Claiborne Cary J | director, officer: Chief Executive Officer | A-Award | Acquired | 300,000 | $0.30 |
| 25 May 2023 | Goodman Tony | director | A-Award | Acquired | 50,000 | $0.30 |
| 25 May 2023 | Anderson J. Kermit | director | A-Award | Acquired | 50,000 | $0.30 |
| 25 May 2023 | Stilley William B. III | director | A-Award | Acquired | 240,800 | $0.00 |
| 25 May 2023 | Stilley William B. III | director | A-Award | Acquired | 50,000 | $0.30 |
| 25 May 2023 | Truluck Joseph | Chief Financial Officer | A-Award | Acquired | 157,500 | $0.00 |
| 25 May 2023 | Truluck Joseph | Chief Financial Officer | A-Award | Acquired | 125,000 | $0.30 |